Tectonic Therapeutic (TECX) Other Accumulated Expenses (2017 - 2024)
Tectonic Therapeutic (TECX) posted quarterly Other Accumulated Expenses of $330000.0 for Q1 2024, up 62.56% year-over-year from $203000.0 in Q2 2023, and down 13.84% quarter-over-quarter from $383000.0 in Q4 2023.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Other Accumulated Expenses (2017 - 2024) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other Accumulated Expenses for 8 consecutive years, with $330000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Other Accumulated Expenses rose 62.56% year-over-year to $330000.0; the TTM figure through Mar 2024 stood at $330000.0 (up 62.56% YoY), while the FY2023 annual figure was $383000.0, up 81.52% from the prior year.
- Other Accumulated Expenses retreated to $330000.0 in Q1 2024 per TECX's latest filing, from $383000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.2 million in Q3 2021 and bottomed at $1000.0 in Q3 2023.
- Historically, Other Accumulated Expenses has averaged $343764.7 across 5 years, with a median of $211000.0 in 2022.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 519.9% — and 2023, when it sank 99.76%.
- Tectonic Therapeutic's Other Accumulated Expenses stood at $348000.0 in 2020, then plunged by 48.85% to $178000.0 in 2021, then increased by 18.54% to $211000.0 in 2022, then soared by 81.52% to $383000.0 in 2023, then fell by 13.84% to $330000.0 in 2024.
- Business Quant data shows TECX's Other Accumulated Expenses at $330000.0 in Q1 2024, $383000.0 in Q4 2023, and $1000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 330,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 409,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 178,000.00 |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 193,000.00 |
| Mar 31, 2021 | 269,000.00 |
| Dec 31, 2020 | 348,000.00 |
| Sep 30, 2020 | 196,000.00 |
| Jun 30, 2020 | 733,000.00 |
| Mar 31, 2020 | 860,000.00 |
| Dec 31, 2019 | 115,000.00 |
| Sep 30, 2019 | 284,000.00 |
| Jun 30, 2019 | 421,000.00 |